Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data…
Zai Lab Reports Promising Phase 1 Results for Zocilurtatug Pelitecan in Extensive-Stage Small Cell Lung Cancer, Launches Global Phase 3 Trial Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has released updated findings from its global Phase 1 clinical trial of…
IVI RMA North America Presents Pioneering Reproductive Medicine Studies at ASRM 2025 IVI RMA North America, a leading provider of fertility care and assisted reproductive technologies, is set to make a significant impact at the upcoming American Society for Reproductive…
HSS Study Finds AI Tool Improves Patient Readiness for Joint Replacement Surgery Preparing for major orthopedic procedures like hip or knee replacement can be an overwhelming experience for patients. The process often brings a flood of questions about pain, recovery,…
Pulse Biosciences Enrolls First Patient in NANOCLAMP AF Study, Marking Major Milestone in Atrial Fibrillation Treatment Innovation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company pioneering next-generation medical technologies through its proprietary nPulse™ platform and Nanosecond Pulsed Field Ablation™ (nsPFA™) energy,…
Coya Therapeutics Prices Upsized $20 Million Public Offering to Advance Treg-Based Therapies for Neurodegenerative Diseases Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company pioneering biologic therapies designed to enhance regulatory T cell (Treg) function in patients suffering from neurodegenerative…
Big-hearted Ryman residents fundraise bumper donation for St John The amazing fundraising initiatives of Ryman residents were recognised after a record donation of $520,517 was presented to charity partner Hato Hone St John on Wednesday. The giant cheque was presented…
Recognized for WuXi Biologics’ outstanding performance and commitment to sustainability and environmental, social, and governance (ESG) excellence. WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced its inclusion in the 2025 Hang Seng Corporate…
Honored with the Achievement Award by the Oligonucleotide Therapeutics Society for pioneering leadership in RNA-targeted therapeutics. Ionis Pharmaceuticals, Inc. today announced that Brett P. Monia, Ph.D., Ionis’ chief executive officer, was awarded the 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society (OTS),…
Strategic Acquisition Combines DocGo’s Last Mile Healthcare Delivery Capabilities With SteadyMD’s Virtual Care Platform; SteadyMD Is Expected To Generate Approximately $25 Million in Revenue in 2025. DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile…
Wolters Kluwer Health Showcases UpToDate Expert AI and Workflow Innovations at HLTH 2025 Wolters Kluwer Health is set to highlight the next generation of clinical decision support with its UpToDate Expert AI at HLTH 2025. Attendees visiting booth #3218 will…
European Infection Control Market 2025–2030: Growth, Trends, and Competitive Landscape The European infection control market is experiencing significant growth and transformation, driven by increasing healthcare demands, technological advancements, and stringent regulatory requirements. ResearchAndMarkets.com has recently added the comprehensive report titled…